Daniela Massi

16.4k total citations · 1 hit paper
396 papers, 10.6k citations indexed

About

Daniela Massi is a scholar working on Oncology, Dermatology and Molecular Biology. According to data from OpenAlex, Daniela Massi has authored 396 papers receiving a total of 10.6k indexed citations (citations by other indexed papers that have themselves been cited), including 221 papers in Oncology, 105 papers in Dermatology and 90 papers in Molecular Biology. Recurrent topics in Daniela Massi's work include Cutaneous Melanoma Detection and Management (140 papers), Nonmelanoma Skin Cancer Studies (55 papers) and Melanoma and MAPK Pathways (50 papers). Daniela Massi is often cited by papers focused on Cutaneous Melanoma Detection and Management (140 papers), Nonmelanoma Skin Cancer Studies (55 papers) and Melanoma and MAPK Pathways (50 papers). Daniela Massi collaborates with scholars based in Italy, United States and United Kingdom. Daniela Massi's co-authors include Vincenzo De Giorgi, Mario Mandalà, Marco Santucci, Alessandro Franchi, Paolo Carli, Richard A. Scolyer, David E. Elder, Torello Lotti, Milena Paglierani and Gianna Baroni and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Investigation and Journal of Clinical Oncology.

In The Last Decade

Daniela Massi

381 papers receiving 10.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The 2018 World Health Organization Classification of Cutaneous, Mucosal, and Uveal Melanoma: Detailed Analysis of 9 Distinct Subtypes Defined by Their Evolutionary Pathway

2020 304 citations Daniela Massi et al. profile →

Peers

Countries citing papers authored by Daniela Massi

Since Specialization

Citations

This map shows the geographic impact of Daniela Massi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniela Massi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniela Massi more than expected).

Fields of papers citing papers by Daniela Massi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniela Massi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniela Massi. The network helps show where Daniela Massi may publish in the future.

Co-authorship network of co-authors of Daniela Massi

This figure shows the co-authorship network connecting the top 25 collaborators of Daniela Massi. A scholar is included among the top collaborators of Daniela Massi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniela Massi. Daniela Massi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Evaluation of Sonidegib Cytoreductive Activity in Locally Advanced Basal Cell Carcinoma Treatment: A Delphi Consensus 2025 ·International Journal of Dermatology ·Paolo A. Ascierto, Maria Concetta Fargnoli, Corrado Caracò, Emi Dika, Mario Mandalà, Daniela Massi, Andrea Paradisi, Aurelio Portincasa, Pietro Quaglino, Paola Queirolo, Luca Tagliaferri, Ketty Peris, (unknown)	0
2	Cutaneous melanoma 2025 ·Nature Reviews Disease Primers ·Alpaslan Tasdogan, Ryan J. Sullivan, Alexander Katalinic, Célèste Lebbé, (unknown), Susana Puig, Lonneke V. van de Poll‐Franse, Daniela Massi, Dirk Schadendorf	17
3	Challenges in developing a digital pathology consultation network: insights from the MELCAYA experience 2025 ·Florence Research (University of Florence) ·(unknown), (unknown), Filippo Ugolini, Anna Szumera‐Ciećkiewicz, Llúcia Alós, Natalia Castrejón de Anta, Stephan Forchhammer, Barbara Valeri, Nicolas Macagno, (unknown), (unknown), (unknown), (unknown), Valerio Gaetano Vellone, (unknown), Rita Alaggio, (unknown), (unknown), Daniela Massi, Claudio J. Conti	0
4	A case series of chorioangiomas in placentas with clinical indication for histological examination 2024 ·Pathologica ·(unknown), (unknown), Franca Castiglione, (unknown), (unknown), Daniela Massi, Viola Seravalli, Mariarosaria Di Tommaso	0
5	Sex-specific and sex hormonal-related differences in melanoma microenvironment 2024 ·SHILAP Revista de lepidopterología ·(unknown), Filippo Ugolini, (unknown), Maria Grazia Giovannini, Daniela Massi	1
6	Combination or sequence of vemurafenib, cobimetinib, and atezolizumab in high-risk, resectable melanoma (NEO-TIM): Primary results. 2024 ·Journal of Clinical Oncology ·Paolo A. Ascierto, Pietro Quaglino, Francesco Spagnolo, Massimo Guidoboni, Michele Del Vecchio, Michele Guida, Ketty Peris, Luisa Fioretto, Virginia Caliendo, Riccardo Marconcini, Paola Queirolo, Corrado Caracò, Simone Mocellin, Maria Grazia Vitale, Domenico Mallardo, Diana Giannarelli, Miriam Paone, Claudia Trojaniello, Daniela Massi, Vanna Chiarion‐Sileni	2
7	TRG-High/ATM-Expressed/SIRT1-Absent Profile as Negative Prognostic Marker after Neoadjuvant Chemotherapy for Gastric Cancer 2023 ·Daniele Lavacchi, (unknown), Fabio Staderini, (unknown), Marco Brugia, (unknown), Laura Fortuna, (unknown), Elisa Giommoni, Elisa Pellegrini, Enrico Caliman, (unknown), Serena Pillozzi, Luca Messerini, Daniela Massi, Fabio Cianchi, Lorenzo Antonuzzo, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown)	1
8	The CAIX inhibitor SLC-0111 exerts anti-cancer activity on gastric cancer cell lines and resensitizes resistant cells to 5-Fluorouracil, taxane-derived, and platinum-based drugs 2023 ·Cancer Letters ·Elena Andreucci, Alessio Biagioni, (unknown), (unknown), Fabio Cianchi, Fabio Staderini, Lorenzo Antonuzzo, Claudiu T. Supuran, (unknown), (unknown), Luca Messerini, Daniela Massi, Matteo Lulli, Jessica Ruzzolini, Silvia Peppicelli, Francesca Bianchini, Nicola Schiavone, Lido Calorini, Lucia Magnelli, Laura Papucci	17
9	The Multidisciplinary Management of Cutaneous Squamous Cell Carcinoma: A Comprehensive Review and Clinical Recommendations by a Panel of Experts 2022 ·Cancers ·Ignazio Stanganelli, Francesco Spagnolo, Giuseppe Argenziano, Paolo A. Ascierto, Franco Bassetto, Paolo Bossi, Vittorio Donato, Daniela Massi, Cesare Massone, Roberto Patuzzo, Giovanni Pellacani, Pietro Quaglino, Paola Queirolo, Iris Zalaudek, Giuseppe Palmieri, (unknown)	17
10	Differential HLA class I subunit (A, B, C heavy chain and β2-microglobulin) expression levels in normal tissues 2022 ·Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin ·Filippo Ugolini, Anna Szumera‐Ciećkiewicz, (unknown), Gabriella Nesi, Mario Mandalà, Soldano Ferrone, Daniela Massi	2
11	Bright-Field Multiplex Immunohistochemistry Assay for Tumor Microenvironment Evaluation in Melanoma Tissues 2022 ·Cancers ·Filippo Ugolini, (unknown), (unknown), Gianna Baroni, Daniela Massi	10
12	Ataxia-Telangiectasia Mutated Loss of Heterozygosity in Melanoma 2022 ·International Journal of Molecular Sciences ·Lorenza Pastorino, Bruna Dalmasso, (unknown), Irene Vanni, Filippo Ugolini, Gianna Baroni, Michela Croce, (unknown), (unknown), Virginia Andreotti, William Bruno, Gabriele Zoppoli, Lorenzo Ferrando, Enrica T. Tanda, Francesco Spagnolo, Chiara Menin, Rosaria Gangemi, Daniela Massi, Paola Ghiorzo	4
13	The TRPA1 Channel Amplifies the Oxidative Stress Signal in Melanoma 2021 ·Cells ·Francesco De Logu, Daniel Souza Monteiro de Araújo, Filippo Ugolini, Luigi Francesco Iannone, (unknown), Francesca Portelli, Lorenzo Landini, Mustafa Titiz, Vincenzo De Giorgi, Pierangelo Geppetti, Daniela Massi, Romina Nassini	13
14	How improvements in monitoring and safety practices lowered airborne formaldehyde concentrations at an Italian university hospital: a summary of 20 years of experience 2020 ·Archives of Industrial Hygiene and Toxicology ·Stefano Dugheri, Daniela Massi, Nicola Mucci, (unknown), Giovanni Cappelli, Giulio Arcangeli	5
15	Extramedullary blastic transformation of primary myelofibrosis in the form of disseminated myeloid sarcoma: a case report and review of the literature 2020 ·Clinical and Experimental Medicine ·Giacomo Coltro, Francesco Mannelli, Federica Vergoni, Raffaella Santi, Daniela Massi, (unknown), Antonella Marzullo, (unknown), Elisabetta Pelo, Annalisa Pacilli, Chiara Paoli, (unknown), Laura Calabresi, Alberto Bosi, Alessandro M. Vannucchi, Paola Guglielmelli	6
16	Folliculotropism in head and neck lentigo maligna and lentigo maligna melanoma 2020 ·JDDG Journal der Deutschen Dermatologischen Gesellschaft ·Emi Dika, Martina Lambertini, Annalisa Patrizi, Cosimo Misciali, Federica Scarfì, Giovanni Pellacani, Victor Desmond Mandel, (unknown), Ignazio Stanganelli, Johanna Chester, Shaniko Kaleci, Daniela Massi, Vincenzo De Giorgi, Élisa Cinotti, Pietro Rubegni, Jean Perrot, Francesca Farnetani	12
17	Improved label‐free diagnostics and pathological assessment of atherosclerotic plaques through nonlinear microscopy 2018 ·Journal of Biophotonics ·(unknown), Gabriella Nesi, Raffaella Santi, Vincenza Maio, Daniela Massi, Carlo Pratesi, Riccardo Cicchi, Francesco S. Pavone	7
18	BRAF/NRAS Mutation Frequencies Among Primary Tumors and Metastases in Patients With Melanoma 2012 ·Journal of Clinical Oncology ·Maria Colombino, Mariaelena Capone, Amelia Lissia, Antonio Cossu, Corrado Rubino, Vincenzo De Giorgi, Daniela Massi, Ester Fonsatti, Stefania Staibano, Oscar Nappi, Elena Pagani, Milena Casula, Antonella Manca, Maria Cristina Sini, Renato Franco, Gerardo Botti, Corrado Caracò, Nicola Mozzillo, Paolo A. Ascierto, Giuseppe Palmieri	360
19	The Comparative Role of Immunohistochemistry and Electron Microscopy in the Identification of Myogenic Differentiation in Soft Tissue Pleomorphic Sarcomas 2005 ·Ultrastructural Pathology ·Alessandro Franchi, Daniela Massi, Marco Santucci	11
20	Cutaneous collision tumour (melanocytic naevus, basal cell carcinoma, seborrhoeic keratosis): a clinical, dermoscopic and pathological case report 2005 ·British Journal of Dermatology ·Vincenzo De Giorgi, Daniela Massi, Serena Sestini, Barbara Alfaioli, (unknown), Paolo Carli	22

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact